Biogen (BIIB) Return on Invested Capital (2009 - 2026)

Biogen (BIIB) has reported Return on Invested Capital for 18 consecutive years, with 0.0% the latest figure, recorded in Q1 2026.

• In Q1 2026, Return on Invested Capital changed 0.0% year-over-year to 0.0%; the TTM figure through Mar 2026 stood at 0.0% (changed 0.0% YoY), while the FY2025 annual figure was 0.0%, changed 0.0% from the prior year.
• Return on Invested Capital came in at 0.0% for Q1 2026 at Biogen, up from 0.0% in the prior quarter.
• The five-year high for Return on Invested Capital was 0.0% in Q1 2022, with the low at 0.0% in Q4 2025.
• Average Return on Invested Capital over 5 years is 0.0%, with a median of 0.0% recorded in 2023.
• The largest YoY upside for Return on Invested Capital was 0 bps in 2022 against a maximum downside of 0 bps in 2022.
• Year by year, Return on Invested Capital stood at 0.0% in 2022, then sank by 128 bps to 0.0% in 2023, then surged by 50 bps to 0.0% in 2024, then plunged by 178 bps to 0.0% in 2025, then jumped by 39 bps to 0.0% in 2026.
• According to Business Quant data, Return on Invested Capital over the past three periods registered 0.0%, 0.0%, and 0.0% for Q1 2026, Q4 2025, and Q3 2025 respectively.